NewAmsterdam Pharma Co N.V annual depreciation and amortization
2021
2022
2023
2024
2025
NewAmsterdam Pharma Co N.V Depreciation & Amortization Growth & History (NAMS)
NewAmsterdam Pharma Co N.V's depreciation and amortization was $220,000 for fiscal 2025.
View full NewAmsterdam Pharma Co N.V company overviewNewAmsterdam Pharma Co N.V annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $220,000 | $107,000 | +94.69% |
| 2024 | 2024-12-31 | $113,000 | $64,000 | +130.61% |
| 2023 | 2023-12-31 | $49,000 | $40,000 | +444.44% |
| 2022 | 2022-12-31 | $9,000 | $4,000 | +80.00% |
| 2021 | 2021-12-31 | $5,000 | — | — |
NewAmsterdam Pharma Co N.V quarterly depreciation and amortization
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $89,000 | −$18,000 | −16.82% |
| Q1 2026 | 2026-03-31 | $62,000 | $10,000 | +19.23% |
| Q4 2025 | 2025-12-31 | $59,000 | — | — |
| Q3 2025 | 2025-09-30 | $125,000 | $36,000 | +40.45% |
| Q2 2025 | 2025-06-30 | $107,000 | $41,000 | +62.12% |
| Q1 2025 | 2025-03-31 | $52,000 | $37,000 | +246.67% |
| Q3 2024 | 2024-09-30 | $89,000 | $75,000 | +535.71% |
| Q2 2024 | 2024-06-30 | $66,000 | $53,000 | +407.69% |
| Q1 2024 | 2024-03-31 | $15,000 | $6,000 | +66.67% |
| Q3 2023 | 2023-09-30 | $14,000 | — | — |
| Q2 2023 | 2023-06-30 | $13,000 | — | — |
| Q1 2023 | 2023-03-31 | $9,000 | — | — |
NewAmsterdam Pharma Co N.V depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, NewAmsterdam Pharma Co N.V's depreciation and amortization increased from $5,000 to $220,000, a change of $215,000. The latest reported quarter, Q2 2026, shows $89,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewAmsterdam Pharma Co N.V source filings ↗